Immunohistochemical analysis in ethinylestradiol-treated breast cancers after prior long-term estrogen-deprivation therapy

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2193-1801

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Immunohistochemical analysis in ethinylestradiol-treated breast cancers after prior long-term estrogen-deprivation therapy ; volume:4 ; number:1 ; day:5 ; month:3 ; year:2015 ; pages:1-9 ; date:12.2015
SpringerPlus ; 4, Heft 1 (5.3.2015), 1-9, 12.2015

Creator: Omoto, Yoko
Takeshita, Takashi
Yamamoto, Yutaka
Yamamoto-Ibusuki, Mutsuko
Hayashi, Mitsuhiro
Sueta, Aiko
Fujiwara, Saori
Taguchi, Tetsuya
Iwase, Hirotaka

Contributor: SpringerLink (Online service)

DOI: 10.1186/s40064-015-0851-8

URN: urn:nbn:de:101:1-2019102806341318522400

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:22 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Omoto, Yoko
Takeshita, Takashi
Yamamoto, Yutaka
Yamamoto-Ibusuki, Mutsuko
Hayashi, Mitsuhiro
Sueta, Aiko
Fujiwara, Saori
Taguchi, Tetsuya
Iwase, Hirotaka
SpringerLink (Online service)

Other Objects (12)

Estrogen receptor of primary breast cancers: evidence for intracellular proteolysis

Estrogen receptor gene (ESR1) amplification occurs rarely in ovarian cancers

Cholesterol biosynthesis pathway as a novel mechanism of resistance to estrogen deprivation in estrogen receptor-positive breast cancer

Emerging potential of parenteral estrogen as androgen deprivation therapy for prostate cancer

Paralemmin-1 is over-expressed in estrogen-receptor positive breast cancers

Role of estrogen receptors and Src signaling in mechanisms of bone metastasis by estrogen receptor positive breast cancers

Estrogen receptor variants in ER-positive basal-type breast cancers responding to therapy like ER-negative breast cancers

Hochschulschrift

Role of BRD4 and histone acetylation in estrogen receptor-positive breast cancers

Estrogen receptor-α signaling in post-natal mammary development and breast cancers

GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers

Estrogen receptor coregulator binding modulator (ERX-11) enhances the activity of CDK4/6 inhibitors against estrogen receptor-positive breast cancers

Proliferation and estrogen signaling can distinguish patients at risk for early versus late relapse among estrogen receptor positive breast cancers

Estrogen receptor of primary breast cancers: evidence for intracellular proteolysis

Estrogen receptor gene (ESR1) amplification occurs rarely in ovarian cancers

Cholesterol biosynthesis pathway as a novel mechanism of resistance to estrogen deprivation in estrogen receptor-positive breast cancer

Emerging potential of parenteral estrogen as androgen deprivation therapy for prostate cancer

Paralemmin-1 is over-expressed in estrogen-receptor positive breast cancers

Role of estrogen receptors and Src signaling in mechanisms of bone metastasis by estrogen receptor positive breast cancers

Estrogen receptor variants in ER-positive basal-type breast cancers responding to therapy like ER-negative breast cancers

Hochschulschrift

Role of BRD4 and histone acetylation in estrogen receptor-positive breast cancers

Estrogen receptor-α signaling in post-natal mammary development and breast cancers

GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers

Estrogen receptor coregulator binding modulator (ERX-11) enhances the activity of CDK4/6 inhibitors against estrogen receptor-positive breast cancers

Proliferation and estrogen signaling can distinguish patients at risk for early versus late relapse among estrogen receptor positive breast cancers

Estrogen receptor of primary breast cancers: evidence for intracellular proteolysis

Estrogen receptor gene (ESR1) amplification occurs rarely in ovarian cancers

Cholesterol biosynthesis pathway as a novel mechanism of resistance to estrogen deprivation in estrogen receptor-positive breast cancer

Emerging potential of parenteral estrogen as androgen deprivation therapy for prostate cancer

Paralemmin-1 is over-expressed in estrogen-receptor positive breast cancers

Role of estrogen receptors and Src signaling in mechanisms of bone metastasis by estrogen receptor positive breast cancers

Estrogen receptor variants in ER-positive basal-type breast cancers responding to therapy like ER-negative breast cancers

Hochschulschrift

Role of BRD4 and histone acetylation in estrogen receptor-positive breast cancers

Estrogen receptor-α signaling in post-natal mammary development and breast cancers

GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers

Estrogen receptor coregulator binding modulator (ERX-11) enhances the activity of CDK4/6 inhibitors against estrogen receptor-positive breast cancers

Proliferation and estrogen signaling can distinguish patients at risk for early versus late relapse among estrogen receptor positive breast cancers

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Immunohistochemical analysis in ethinylestradiol-treated breast cancers after prior long-term estrogen-deprivation therapy

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Estrogen receptor of primary breast cancers: evidence for intracellular proteolysis

Estrogen receptor gene (ESR1) amplification occurs rarely in ovarian cancers

Cholesterol biosynthesis pathway as a novel mechanism of resistance to estrogen deprivation in estrogen receptor-positive breast cancer

Emerging potential of parenteral estrogen as androgen deprivation therapy for prostate cancer

Paralemmin-1 is over-expressed in estrogen-receptor positive breast cancers

Role of estrogen receptors and Src signaling in mechanisms of bone metastasis by estrogen receptor positive breast cancers

Estrogen receptor variants in ER-positive basal-type breast cancers responding to therapy like ER-negative breast cancers

Role of BRD4 and histone acetylation in estrogen receptor-positive breast cancers

Estrogen receptor-α signaling in post-natal mammary development and breast cancers

GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers

Estrogen receptor coregulator binding modulator (ERX-11) enhances the activity of CDK4/6 inhibitors against estrogen receptor-positive breast cancers

Proliferation and estrogen signaling can distinguish patients at risk for early versus late relapse among estrogen receptor positive breast cancers

Estrogen receptor of primary breast cancers: evidence for intracellular proteolysis

Estrogen receptor gene (ESR1) amplification occurs rarely in ovarian cancers

Cholesterol biosynthesis pathway as a novel mechanism of resistance to estrogen deprivation in estrogen receptor-positive breast cancer

Emerging potential of parenteral estrogen as androgen deprivation therapy for prostate cancer

Paralemmin-1 is over-expressed in estrogen-receptor positive breast cancers

Role of estrogen receptors and Src signaling in mechanisms of bone metastasis by estrogen receptor positive breast cancers

Estrogen receptor variants in ER-positive basal-type breast cancers responding to therapy like ER-negative breast cancers

Role of BRD4 and histone acetylation in estrogen receptor-positive breast cancers

Estrogen receptor-α signaling in post-natal mammary development and breast cancers

GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers

Estrogen receptor coregulator binding modulator (ERX-11) enhances the activity of CDK4/6 inhibitors against estrogen receptor-positive breast cancers

Proliferation and estrogen signaling can distinguish patients at risk for early versus late relapse among estrogen receptor positive breast cancers

Estrogen receptor of primary breast cancers: evidence for intracellular proteolysis

Estrogen receptor gene (ESR1) amplification occurs rarely in ovarian cancers

Cholesterol biosynthesis pathway as a novel mechanism of resistance to estrogen deprivation in estrogen receptor-positive breast cancer

Emerging potential of parenteral estrogen as androgen deprivation therapy for prostate cancer

Paralemmin-1 is over-expressed in estrogen-receptor positive breast cancers

Role of estrogen receptors and Src signaling in mechanisms of bone metastasis by estrogen receptor positive breast cancers

Estrogen receptor variants in ER-positive basal-type breast cancers responding to therapy like ER-negative breast cancers

Role of BRD4 and histone acetylation in estrogen receptor-positive breast cancers

Estrogen receptor-α signaling in post-natal mammary development and breast cancers

GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers

Estrogen receptor coregulator binding modulator (ERX-11) enhances the activity of CDK4/6 inhibitors against estrogen receptor-positive breast cancers

Proliferation and estrogen signaling can distinguish patients at risk for early versus late relapse among estrogen receptor positive breast cancers

Related objects

Reset password